Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 19, 2024 09:15 ET | Source: Kaida Biopharma

Kaida BioPharma Announces Formation of Scientific Advisory Board to Support Development of KAD101 for Ovarian Cancer

Company appoints Anil K. Sood, MD, as inaugural member Company continues to advance lead program, KAD101 for the treatment of ovarian cancer rapidly advancing towards Phase 1 study, targeted for 2025...
September 18, 2024 10:00 ET | Source: Kaida Biopharma

Kaida BioPharma Launches Social Media Channels

Company dedicated to providing a new hope for patients with treatment-resistant gynecological cancers Lead program, KAD101 for the treatment of ovarian cancer rapidly advancing towards Phase 1...
June 17, 2024 07:30 ET | Source: Kaida Biopharma

Kaida BioPharma to Present at the Virtual Investor Pitch Conference

Live webcast on Monday, June 17th at 9:00 AM ET FORT LAUDERDALE, FL, June 17, 2024 (GLOBE NEWSWIRE) -- Kaida BioPharma (“Kaida” or the “Company”), an early-stage pharma company dedicated to...
November 02, 2023 10:00 ET | Source: Transparency Market Research

Ovarian Cancer Treatment Market To Reach USD 18.3 Billion By 2031. By TMR

Wilmington, Delaware, United States, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global ovarian cancer treatment market was estimated to have acquired US$ 5.1 billion...
September 14, 2021 20:00 ET | Source: DelveInsight Business Research LLP

Ovarian Cancer Clinical Trials | A Drug Pipeline Analysis Report 2021 | DelveInsight

Los Angeles, USA, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Ovarian Cancer Clinical Trials | A Drug Pipeline Analysis Report 2021 | DelveInsight Around 100+ key companies are developing therapies for...